The global craniopharyngioma treatment market size was valued at USD 600.50 Million in 2024 and is expected to reach USD 957.10 Million by 2032, at a CAGR of 6.00% during the forecast period
The market growth is largely fueled by the growing advancements in diagnostic imaging technologies and the development of targeted therapies, leading to improved detection and treatment outcomes for patients with craniopharyngioma
Furthermore, rising awareness of rare brain tumors, increasing investment in neuro-oncology research, and the availability of advanced surgical and radiotherapy techniques are driving the adoption of Craniopharyngioma Treatment solutions, thereby significantly boosting the industry's growth
4 weergaven